Cargando…

Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample

AIMS/HYPOTHESIS: Accurate prediction of disease progression in individuals with pre-symptomatic type 1 diabetes has potential to prevent ketoacidosis and accelerate development of disease-modifying therapies. Current tools for predicting risk require multiple blood samples taken during an OGTT. Our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bediaga, Naiara G., Li-Wai-Suen, Connie S. N., Haller, Michael J., Gitelman, Stephen E., Evans-Molina, Carmella, Gottlieb, Peter A., Hippich, Markus, Ziegler, Anette-Gabriele, Lernmark, Ake, DiMeglio, Linda A., Wherrett, Diane K., Colman, Peter G., Harrison, Leonard C., Wentworth, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494707/ https://www.ncbi.nlm.nih.gov/pubmed/34338806 http://dx.doi.org/10.1007/s00125-021-05523-2

Ejemplares similares

4033 Evaluating the Effect of Prebiotics on the Gut Microbiome Profile and Beta-cell Function in Newly-Diagnosed Type 1 Diabetes
por: Ismail, Heba M, et al.
Publicado: (2020)

LBSUN309 The Effect Of Prebiotics In Newly Diagnosed Youth With Type 1 Diabetes (T1D)
por: Ismail, Heba, et al.
Publicado: (2022)

57437 Effects of Prebiotics on the Gut Microbiome Profile, Beta-cell Function and Immune Markers in Newly-Diagnosed Type 1 Diabetes
por: Ismail, Heba M., et al.
Publicado: (2021)

Evaluating the effect of prebiotics on the gut microbiome profile and β cell function in youth with newly diagnosed type 1 diabetes: protocol of a pilot randomized controlled trial
por: Ismail, Heba M., et al.
Publicado: (2023)

Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report
por: Wherrett, Diane K., et al.
Publicado: (2015)

Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials
por: Nathan, Brandon M., et al.
Publicado: (2017)

Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA(1c), and Insulin Dose
por: Hao, Wei, et al.
Publicado: (2016)

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
por: Orban, Tihamer, et al.
Publicado: (2014)

A classification and regression tree analysis identifies subgroups of childhood type 1 diabetes
por: Achenbach, Peter, et al.
Publicado: (2022)

Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials
por: Kinney, Mara, et al.
Publicado: (2023)

Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study
por: Beyerlein, Andreas, et al.
Publicado: (2019)

Elevations in Circulating Methylated and Unmethylated Preproinsulin DNA in New-Onset Type 1 Diabetes
por: Fisher, Marisa M., et al.
Publicado: (2015)

Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review
por: Felton, Jamie L., et al.
Publicado: (2023)

β-Cell Glucose Sensitivity to Assess Changes in β-Cell Function in Recent-Onset Stage 3 Type 1 Diabetes
por: Gitelman, Stephen E., et al.
Publicado: (2023)

Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial
por: Russell, William E., et al.
Publicado: (2023)

Analysis of serum Hsp90 as a potential biomarker of β cell autoimmunity in type 1 diabetes
por: Ocaña, Gail J., et al.
Publicado: (2019)

Genetic Contribution to the Divergence in Type 1 Diabetes Risk Between Children From the General Population and Children From Affected Families
por: Hippich, Markus, et al.
Publicado: (2019)

A public health antibody screening indicates a marked increase of SARS-CoV-2 exposure rate in children during the second wave
por: Hippich, Markus, et al.
Publicado: (2021)

Simplified endoscopic septotomy for a large symptomatic Zenkerʼs diverticulum
por: Asokkumar, Ravishankar, et al.
Publicado: (2023)

Growth and Risk for Islet Autoimmunity and Progression to Type 1 Diabetes in Early Childhood: The Environmental Determinants of Diabetes in the Young Study
por: Elding Larsson, Helena, et al.
Publicado: (2016)

The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report
por: Krischer, Jeffrey P., et al.
Publicado: (2017)

Depleting T Cells in Newly Diagnosed Autoimmune (Type 1) Diabetes—Are We Getting Anywhere?
por: Lernmark, Åke
Publicado: (2013)

Etiology of Autoimmune Islet Disease: Timing Is Everything
por: Lernmark, Åke
Publicado: (2021)

Methylglyoxal products in pre-symptomatic type 1 diabetes
por: Shuck, Sarah C., et al.
Publicado: (2023)

Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children
por: Bonifacio, Ezio, et al.
Publicado: (2018)

Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories
por: Kwon, Bum Chul, et al.
Publicado: (2022)

Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study
por: Krischer, Jeffrey P., et al.
Publicado: (2017)

SARS-CoV-2 — No Increased Islet Autoimmunity or Type 1 Diabetes in Teens
por: Krischer, Jeffrey P., et al.
Publicado: (2023)

Content analysis of locum tenens recruitment emails for anesthesiologists
por: DiMeglio, Matthew, et al.
Publicado: (2018)

Self-Assessment of Preparedness among Critical Care Trainees Transitioning from Fellowship to Practice
por: Watkins, Laura, et al.
Publicado: (2019)

Cause or effect? A review of clinical data demonstrating beta cell dysfunction prior to the clinical onset of type 1 diabetes
por: Sims, Emily K., et al.
Publicado: (2019)

The Impact of an International Elective on Anesthesiology Residents as Assessed by a Longitudinal Study
por: Dohlman, Lena, et al.
Publicado: (2019)

Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes
por: Beam, Craig A., et al.
Publicado: (2021)

A pilot study of the feasibility of empagliflozin in recent-onset type 1 diabetes
por: Wentworth, John M., et al.
Publicado: (2020)

THU180 Evaluation Of Factors Affecting Changes In Body Mass Index In Childhood Brain Tumor Survivors
por: Chatila, Dana, et al.
Publicado: (2023)

Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children
por: Elding Larsson, Helena, et al.
Publicado: (2017)

Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies
por: Mesa, Ruben A., et al.
Publicado: (2023)

A method for reporting and classifying acute infectious diseases in a prospective study of young children: TEDDY
por: Lönnrot, Maria, et al.
Publicado: (2015)

HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
por: Salami, Falastin, et al.
Publicado: (2022)

Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
por: Insel, Richard A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c4bfbum3dgm0bqdh3s6ce8chvq